Resultats de la cerca - Juan Gonzalez‐Maffe

  • Mostrar 1 - 5 resultats de 5
Refinar resultats
  1. 1
    Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia

    Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia per Tricia Tan, Benjamin Field, Katherine McCullough, R. Troke, Edward S. Chambers, Victoria Salem, Juan Gonzalez Maffe, Kevin Baynes, Akila De Silva, Alexander Viardot, Ali Alsafi, Gary Frost, Mohammad A. Ghatei, Stephen R. Bloom

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Reduced Levels of Plasma Kisspeptin During the Antenatal Booking Visit Are Associated With Increased Risk of Miscarriage

    Reduced Levels of Plasma Kisspeptin During the Antenatal Booking Visit Are Associated With Increased Risk of Miscarriage per Channa Jayasena, Ali Abbara, Chioma Izzi‐Engbeaya, Alexander Comninos, Richard Harvey, Juan Gonzalez Maffe, Zubair Sarang, Zainab Ganiyu‐Dada, Ana Padilha, M. Dhanjal, Catherine Williamson, L. Regan, Mohammad A. Ghatei, Stephen R. Bloom, Waljit S. Dhillo

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women

    Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women per Rufus Cartwright, Anna C. Kirby, Kari A.O. Tikkinen, Altaf Mangera, Gans Thiagamoorthy, Prabhakar Rajan, Jori S. Pesonen, Chris Ambrose, Juan Gonzalez‐Maffe, Phillip R. Bennett, Tom Palmer, Andrew J. Walley, Marjo‐Riitta Järvelin, Christopher R. Chapple, Vik Khullar

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma

    A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma per Sophie Piperno‐Neumann, Matteo S. Carlino, Valentina Boni, D. Loirat, Frank M. Speetjens, John Park, Emiliano Calvo, Richard D. Carvajal, M. Nyakas, Juan Gonzalez‐Maffe, Xiaobo Zhu, Matthew D. Shirley, Thiruvamoor Ramkumar, A. Fessehatsion, Hannah Burks, Padmaja Yerramilli-Rao, Ellen Kapiteijn

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

    Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer per Caroline Even, Hung‐Ming Wang, Shau-Hsuan Li, Roger K.C. Ngan, Arunee Dechaphunkul, Li Zhang, Chia‐Jui Yen, Po Chung Chan, Somvilai Chakrabandhu, Brigette Ma, Suebpong Tanasanvimon, Victor Lee, Pei‐Jen Lou, Zujun Li, Alexander I. Spira, Ammar Sukari, J. Guigay, Steven McCune, Juan Gonzalez‐Maffe, Sebastian Szpakowski, Yao Yao, Hongzi Liang, Jennifer Mataraza, Romain Séchaud, Luigi Manenti, Wan‐Teck Lim

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: